<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00093054</url>
  </required_header>
  <id_info>
    <org_study_id>R01AT002086</org_study_id>
    <nct_id>NCT00093054</nct_id>
  </id_info>
  <brief_title>Cranberry Juice for Treatment of Urinary Tract Infections</brief_title>
  <official_title>Cranberry Juice and Urinary Tract Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether daily consumption of cranberry juice
      lessens the symptoms and prevents the recurrence of urinary tract infections (UTIs). This
      study will also determine whether drinking cranberry juice for 6 months selects for less
      virulent bacteria in the rectal, vaginal, and urethral areas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants in this study will be randomly assigned to consume either 8 ounces of cranberry
      juice or placebo juice twice a day for 6 months. Participants will have follow-up visits at 3
      and 6 months, and whenever they experience a symptomatic episode. Urine, vaginal and rectal
      specimens will be taken at each visit to test for the presence of bacteria that cause urinary
      tract infections. Participants will complete a questionnaire at study entry, Day 3, Weeks 1
      and 2, and monthly thereafter or whenever there is a recurrence of symptoms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Culture</measure>
    <time_frame>per visit</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">319</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cranberry juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo juice</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cranberry juice</intervention_name>
    <description>TID dosage for UTI treatment</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo cranberry juice</intervention_name>
    <description>TID placebo dosage to match active comparator</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Culture-confirmed urinary tract infection at study start

        Exclusion Criteria:

          -  Other chronic disease

          -  Antibiotics within 48 hours prior to study start

          -  Hospitalization for any reason within 2 weeks prior to study start

          -  Stones in urinary tract

          -  Plans to leave Ann Arbor within 6 months after study start

          -  Allergy to cranberry or cranberry compounds

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cibele T. Barbosa-Cesnik</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2004</study_first_submitted>
  <study_first_submitted_qc>September 30, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2004</study_first_posted>
  <disposition_first_submitted>April 14, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>April 14, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">May 5, 2015</disposition_first_posted>
  <last_update_submitted>April 14, 2015</last_update_submitted>
  <last_update_submitted_qc>April 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaccinium macrocarpon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

